Goodwin has advised the European private equity firm EMZ Partners on the financing of the acquisition of a significant stake in H&Z Unternehmensberatung. H&Z Management Consulting...
EMZ Partners’ Investment in H&Z Group
HI-Bio’s $95 Million Series B Financing Round
Goodwin advised Human Immunology Biosciences (HI-Bio) on the round. Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs),...
Concentra Biosciences’ $185 Million Acquisition of Theseus Pharmaceuticals
Goodwin advised Theseus Pharmaceuticals on the sale to Concentra Biosciences, assisted by Gibson, Dunn & Crutcher LLP. Leerink Partners acted as Theseus’ financial advisor. Theseus Pharmaceuticals,...
Bristol Myers Squibb’s $4.1 Billion Acquisition of RayzeBio
Covington advised Bristol Myers Squibb on the transaction, while Cooley and Wilson Sonsini Goodrich & Rosati advised RayzeBio Inc. Goodwin advised Centerview Partners in its role...
Orrstown Financial Services’ Merger with Codorus Valley Bancorp
Raymond James & Associates, Inc. acted as financial advisor to Orrstown and delivered a fairness opinion to the Board of Directors of Orrstown. Goodwin Procter LLP...
Maine Community Bank’s Merger with Gorham Savings Bank
Piper Sandler & Co. served as financial advisor to Gorham Savings Bank, and Performance Trust Capital Partners served as financial advisor to Maine Community Bank. Goodwin...
BID Equity’s Refinancing of JustRelate
Goodwin advised Norddeutsche Landesbank and Oldenburgische Landesbank Aktiengesellschaft in connection with the refinancing of JustRelate Group, including the financing of the acquisition of French Bmobile and...
TA and Warburg Pincus’ Acquisition of Exercite Group
Goodwin, Kirkland & Ellis and Paul Weiss advised TA and Warburg Pincus on the acquisition of Epassi and the combination with Exercite. Hengeler Mueller advised Waterland....
AstraZeneca’s $1.1 Billion Acquisition of Icosavax
Centerview Partners LLC is serving as exclusive financial advisor to Icosavax and Goodwin is serving as legal counsel. Icosavax, Inc. (Nasdaq: ICVX) announced it has entered...
SpringWorks Therapeutics’ $316.25 Million Underwritten Common Stock Offering
Goodwin advised SpringWorks Therapeutics, Inc. on the offering. American precision medicine company SpringWorks Therapeutics (Nasdaq: SWTX) has closed a public offering of 10,905,171 shares of its common...
Deutsche Invest’s Acquisition Financing for Wirtz
Goodwin has advised Deutsche Invest Capital Partners on the financing of the acquisition of Wirtz Werkzeugbau GmbH (“Wirtz”) via its special situations strategy, DI Mittelstand. Deutsche...
Pathos AI’s Acquisition of Rain Oncology
Leerink Partners is acting as exclusive financial advisor and Gibson, Dunn & Crutcher LLP is acting as legal counsel to Rain. Goodwin Procter LLP is acting...